Literature DB >> 20602681

Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration.

Mónica Guevara1, María E Baccaro, Jose Ríos, Marta Martín-Llahí, Juan Uriz, Luis Ruiz del Arbol, Ramón Planas, Alberto Monescillo, Carlos Guarner, Javier Crespo, Rafael Bañares, Vicente Arroyo, Pere Ginès.   

Abstract

Hyponatraemia is common in patients with advanced cirrhosis and is associated with remarkable changes in brain cells, particularly a reduction in myoinositol and other intracellular organic osmolytes related to the hypo-osmolality of the extracellular fluid. It has been recently suggested that hyponatraemia may be an important factor associated with the development of overt hepatic encephalopathy (HE). To test this hypothesis, we retrospectively analysed the incidence and predictive factors of overt HE using a database of 70 patients with cirrhosis included in a prospective study comparing transjugular intrahepatic portosystemic shunts (TIPS) vs large-volume paracentesis in the management of refractory of ascites. Variables used in the analysis included age, sex, previous history of HE, treatment assignment (TIPS vs large volume paracentesis plus albumin), treatment with diuretics, serum bilirubin, serum creatinine and serum sodium concentration. Laboratory parameters were measured at entry, at 1 month and every 3 months during follow-up and at the time of development of HE in patients who developed this complication. During a mean follow-up of 10 months, 50 patients (71%) developed 117 episodes of HE. In the whole population of patients, the occurrence of HE was independently associated with serum hyponatraemia, serum bilirubin and serum creatinine. In conclusion, in patients with refractory ascites, the occurrence of HE is related to the impairment of liver and renal function and presence of hyponatraemia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20602681     DOI: 10.1111/j.1478-3231.2010.02293.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  29 in total

1.  Cognitive Impairment Predicts The Occurrence Of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt.

Authors:  Silvia Nardelli; Stefania Gioia; Chiara Pasquale; Ilaria Pentassuglio; Alessio Farcomeni; Manuela Merli; Filippo Maria Salvatori; Leandra Nikolli; Sabrina Torrisi; Francesca Greco; Valeria Nicoletti; Oliviero Riggio
Journal:  Am J Gastroenterol       Date:  2016-03-01       Impact factor: 10.864

2.  Hyponatremia and Its Correlation With Hepatic Encephalopathy and Severity of Liver Disease.

Authors:  Amna Younas; Junaid Riaz; Tamoor Chughtai; Hamza Maqsood; Muhammad Saim; Shaheryar Qazi; Shifa Younus; Umar Ghaffar; Muhammad Khaliq
Journal:  Cureus       Date:  2021-02-06

Review 3.  Hyponatraemia: more than just a marker of disease severity?

Authors:  Robert W Schrier; Shailendra Sharma; Dmitry Shchekochikhin
Journal:  Nat Rev Nephrol       Date:  2012-11-20       Impact factor: 28.314

4.  A New Look at Precipitants of Overt Hepatic Encephalopathy in Cirrhosis.

Authors:  Ganesh Pantham; Anthony Post; Deepak Venkat; Douglas Einstadter; Kevin D Mullen
Journal:  Dig Dis Sci       Date:  2017-05-30       Impact factor: 3.199

Review 5.  Outcomes of transjugular intrahepatic portosystemic shunts for ascites.

Authors:  Zachary L Bercu; Aaron M Fischman
Journal:  Semin Intervent Radiol       Date:  2014-09       Impact factor: 1.513

6.  Hyponatremia and Hepatorenal Syndrome.

Authors:  Arpan Mohanty; Guadalupe Garcia-Tsao
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-04

Review 7.  The Changing Role of Sodium Management in Cirrhosis.

Authors:  Blanca Lizaola; Alan Bonder; Elliot B Tapper; Angela Mendez-Bocanegra; Andres Cardenas
Journal:  Curr Treat Options Gastroenterol       Date:  2016-06

Review 8.  Satavaptan treatment for ascites in patients with cirrhosis: a meta-analysis of effect on hepatic encephalopathy development.

Authors:  Hugh Watson; Peter Jepsen; Florence Wong; Pere Ginès; Juan Córdoba; Hendrik Vilstrup
Journal:  Metab Brain Dis       Date:  2013-03-06       Impact factor: 3.584

9.  Predictive value of induced hyperammonaemia and neuropsychiatric profiling in relation to the occurrence of post-TIPS hepatic encephalopathy.

Authors:  Marco Senzolo; Lisa Zarantonello; Chiara Formentin; Costanza Orlando; Raffaello Beltrame; Anna Vuerich; Paolo Angeli; Patrizia Burra; Sara Montagnese
Journal:  Metab Brain Dis       Date:  2019-09-10       Impact factor: 3.584

10.  Osmotic Shifts, Cerebral Edema, and Neurologic Deterioration in Severe Hepatic Encephalopathy.

Authors:  Eric Michael Liotta; Anna L Romanova; Bryan D Lizza; Laura J Rasmussen-Torvik; Minjee Kim; Brandon Francis; Rajbeer Singh Sangha; Timothy J Carroll; Daniel Ganger; Daniela P Ladner; Andrew M Naidech; James J Paparello; Shyam Prabhakaran; Farzaneh A Sorond; Matthew B Maas
Journal:  Crit Care Med       Date:  2018-02       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.